Obesity PCT dosing/info (final)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/46

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

47 Terms

1
New cards

phentermine (Adipex-P) dose

15 to 37.5 mg PO QD (1 or 2 divided doses)

2
New cards

phentermine is for long-term or short-term (3 months) use?

short-term

3
New cards

phentermine IR dose

25 mg IR PO TID

4
New cards

phentermine SR dose

75 mg PO QD

5
New cards

Adipex-P MOA

sympathomimetic; increases norepinephrine; suppresses appetite

6
New cards

phentermine MOA (Qsymia)

sympathomimetic; increases norepinephrine; suppresses appetite

7
New cards

topiramte MOA (Qsymia)

effects neurotransmitters/ion channels; suppresses appetite; enchances satiety

8
New cards

phentermine + topiramate (Qsymia) initial dose

3.75/25 mg PO QAM x 14 days; then 7.5/46 mg x 12 weeks

9
New cards

phentermine + topiramate (Qsymia) max dose

15/92 mg

10
New cards

if using Qsymia as PCT, and 3% of baseline body weight has not been achieved, increase dose from 7.5/46 mg to?

11.25/69 mg PO QAM x 14 days; then 15/92 mg x 12 weeks

11
New cards

Qsymia has which significant adverse effect?

paresthesias

12
New cards

bupropion MOA (Contrave)

reduces appetite

13
New cards

naltrexone MOA (Contrave)

reduces food cravings and enhances bupropion

14
New cards

bupropion + naltrexone (Contrave) dose

90/8 mg PO QAM x 7 days; then titrated weekly to 180/16 mg PO BID with non-fatty meals

15
New cards

Contraves end titration goal resuslts in how many total pills per day?

4

16
New cards

liraglutide MOA (Saxenda)

GLP-1 agonist; delays gastric emptying; promotes satiety

17
New cards

liraglutide (Saxenda) initial dose

0.6 mg SC QD x 1 week

18
New cards

liraglutide (Saxenda) titration increments

0.6 mg

19
New cards

liraglutide (Saxenda) max dose

3 mg QD

20
New cards

liraglutide (Saxenda) titration schedule?

weekly

21
New cards

semaglutide MOA (Wegovy)

GLP-1 agonist; delays gastric emptying; promotes satiety

22
New cards

semaglutide (Wegovy) initial dose

0.25 mg SC Q week x 4 weeks

23
New cards

Wegovy titration schedule

monthly

24
New cards

Wegovy max dose

2.4 mg

25
New cards

wegovy month 1 dose

0.25 mg

26
New cards

wegovy month 2 dose

0.5 mg

27
New cards

wegovy month 3 dose

1 mg

28
New cards

wegovy month 4 dose

1.7 mg

29
New cards

wegovy month 5 dose

2.4 mg

30
New cards

wegovy maintenance dose

1.7 or 2.4 mg

31
New cards

tirzepatide MOA (Zepbound)

GLP-1/GIP agonist; delays gastric empting; promotes satiety

32
New cards

tirzepatide (Zepbound) initial dose

2.5 mg SC Q week x 4 weeks

33
New cards

tirzepatide titration schedule?

monthly

34
New cards

tirzepatide max dose

15 mg

35
New cards

tirzepatide maintenance dose

5, 10, or 15 mg

36
New cards

Zepbound month 1 dose

2.5 mg

37
New cards

Zepbound month 2 dose

5 mg

38
New cards

Zepbound month 3 dose

7.5 mg

39
New cards

Zepbound month 4 dose

10 mg

40
New cards

Zepbound month 5 dose

12.5 mg

41
New cards

Zepbound month 6 dose

15 mg

42
New cards

liraglutide, semaglutide, and tirzepatide all share what common significant adverse effect?

dose-dependent nausea

43
New cards

tirzepatide has which significant DDI

oral contraceptives

44
New cards

semaglutide and tirzepatide have high efficacy on?

A1c; weight

45
New cards

tirzepatide has a benefit on which comorbidity?

OSA

46
New cards

semaglutide has a benefit on which 2 comorbidities?

MASH; CV reduction

47
New cards

of semaglutide and tirzepatide which is more efficacious?

tirzepatide